Breaking News
October 24, 2018 - New 17-item questionnaire may help detect GI disorders in children with autism
October 24, 2018 - 12% of frequent marijuana smokers experience cannabis withdrawal syndrome
October 24, 2018 - Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis
October 24, 2018 - Poor Experience With PCP Linked to Hospitalization in CKD
October 23, 2018 - Dummies not to blame for common speech disorder in kids
October 23, 2018 - The future of ethics and biomedicine: An interview
October 23, 2018 - X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma
October 23, 2018 - FDA targets 465 websites that sell potentially dangerous, unapproved drugs
October 23, 2018 - New approach may lead to better diagnostic techniques for autoimmune disorders
October 23, 2018 - Innovative computer software sheds new light on genetic processes underlying deadly diseases
October 23, 2018 - Juul Drawing Lots of Teen Followers on Twitter
October 23, 2018 - WHO says Zika risk low in Pacific ahead of Meghan visit
October 23, 2018 - A deeper look at ‘Reflecting Frankenstein’
October 23, 2018 - Breastfeeding can have protective affect against high blood pressure in women, confirms study
October 23, 2018 - Epigenetic modifications may contribute to Alzheimer’s Disease
October 23, 2018 - Volunteering for peer counseling programs benefits people with lupus
October 23, 2018 - Cancer treatment may undergo a paradigm shift to immunotherapy soon
October 23, 2018 - Study uncovers new mechanism of action in a first-line drug for diabetes
October 23, 2018 - New type of molecule shows early promise against treatment-resistant prostate cancer
October 23, 2018 - Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients
October 23, 2018 - Scientists grow functioning human neural networks in 3D from stem cells
October 23, 2018 - Using mushrooms as a prebiotic may help improve glucose regulation
October 23, 2018 - New ENT clinic treats children in Zimbabwe
October 23, 2018 - CUIMC Celebrates 2018-2019, Issue 2
October 23, 2018 - Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer
October 23, 2018 - ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use
October 23, 2018 - Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage
October 23, 2018 - Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics
October 23, 2018 - Lowering systolic blood pressure does not damage the kidneys, shows study
October 23, 2018 - Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
October 23, 2018 - Cardiovascular admissions more common among most deprived
October 23, 2018 - Targeted drug and hormone therapy combination extends breast cancer survival
October 23, 2018 - Map of human liver cells reveals molecular make-up of individual cells
October 23, 2018 - Drugs approved for breast cancer treatment are effective and well tolerated in men
October 23, 2018 - EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring
October 23, 2018 - Researchers identify common genetic connection in lung conditions
October 23, 2018 - Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC
October 23, 2018 - Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer
October 23, 2018 - New discovery may lead to better treatment options for pancreatic cancer patients
October 23, 2018 - FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
October 23, 2018 - Researchers identify immune culprits linked to inflammation and bone loss in gum disease
October 23, 2018 - Despite lower risk factors, black men have higher rates of recidivism
October 23, 2018 - Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery
October 23, 2018 - AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis
October 23, 2018 - NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
October 23, 2018 - Scientists use electron microscope to study chemical transformation in catalytic cross-coupling reaction
October 23, 2018 - Research offers new hope to men who received childhood cancer treatment
October 23, 2018 - New medical navigation system receives international innovation award
October 23, 2018 - Adverse Childhood Experiences Tied to Burnout in BSN Students
October 23, 2018 - High levels of oral disease among elite athletes affecting performance
October 23, 2018 - Study examines effect of immediate vs delayed pushing during labor on delivery outcomes
October 23, 2018 - LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations
October 23, 2018 - Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients
October 23, 2018 - Organic food may protect against cancers finds study
October 23, 2018 - Interweaving anxiety disorder associated with stuttering remains unrecognized
October 23, 2018 - Cannabis oil shown to significantly improve Crohn’s disease symptoms
October 23, 2018 - Knowledge of sex differences in lower urinary tract may help stimulate breakthroughs in diagnosis, management
October 23, 2018 - Common antibodies associated with myocardial infarction
October 23, 2018 - Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy
October 23, 2018 - Brain’s ‘Self-Control’ Center May Be Key to Weight-Loss Success
October 23, 2018 - Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death
October 23, 2018 - Can virtual reality help people become more compassionate?
October 23, 2018 - Screen time eclipsed outdoor time for most students, shows study
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
Dolphin brains show signs of Alzheimer’s Disease

Dolphin brains show signs of Alzheimer’s Disease

image_pdfDownload PDFimage_print
Credit: Shutterstock

Study suggests Alzheimer’s disease and Type 2 diabetes might both be the price of a longer lifespan, with altered insulin function the common cause.

A review led by Professor Simon Lovestone, an old age psychiatrist from Oxford Health NHS Foundation Trust, found that humans were almost unique in having Alzheimer’s disease. This is the first study to find unambiguous signs of the disease in a wild animal.

“It is very rare to find signs of full-blown Alzheimer’s disease in non-human brains,” said Professor Lovestone, who is also researcher within the Oxford University Department of Psychiatry and the dementia theme lead for the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC). “This is the first time anyone has found such clear evidence of the protein plaques and tangles associated with Alzheimer’s disease in the brain of a wild animal.”

Humans are also almost unique in living long after they are capable of having children; fertility in both men and women declines sharply around the age of 40, but people can go on to live as long as 110 years. Other animals tend to die shortly after the end of their fertile years.

In a study published in the journal Alzheimer’s and Dementia, researchers tested the idea that living long after the end of fertility might be linked to Alzheimer’s disease, by studying the brains of another species which can live long after having offspring: dolphins.

The team (which included scientists from the Universities of St. Andrews and Edinburgh in Scotland, the University of Florida in the USA, and the University of Oxford in England) found signs of Alzheimer’s disease in the brains of dolphins which had died after washing up ashore on the Spanish coast.

“It was a moment of serendipity when I heard Simon give a talk about the possibility that dolphins might be predicted to get dementia, as our collaborators have previously worked with dolphins,” said Professor Frank Gunn-Moore from the University of St Andrews.

“This study shows the importance of comparative research when considering important questions-non-human animals have so much to tell us about dementia, not just as ‘models’ for Alzheimer’s disease in people, but also to improve our understanding of dementia in these animals,” said Professor Danièlle Gunn-Moore from the University of Edinburgh and the Roslin Institute, who is the first author on this study.

The team analysed ‘plaques’ of a protein called beta amyloid in the brains of dolphins, as well as tangles of another protein called tau: these plaques and tangles are signatures of Alzheimer’s disease.

The team think that humans and dolphins are near-uniquely susceptible to Alzheimer’s disease because of alterations in how the hormone insulin works in these species. Insulin regulates the levels of sugar in the blood, and sets off a complex chemical cascade known as insulin signalling. While alterations in insulin signalling can cause diabetes in people and other mammals, previous scientific work also found that extreme calorie restriction in some animals (e.g. mice and fruit flies) altered insulin signalling – and extended the animals’ lifespan by up to three times.

“We think that in humans, the insulin signalling has evolved to work in a way similar to that artificially produced by giving a mouse very few calories,” says Professor Lovestone. “That has the effect of prolonging lifespan beyond the fertile years, but it also leaves us open to diabetes and Alzheimer’s disease. Previous work shows that insulin resistance predicts the development of Alzheimer’s disease in people, and people with diabetes are more likely to develop Alzheimer’s.”

“But our study suggests that dolphins and orcas (who also have a long post fertility life span) are similar to humans in many ways; they have an insulin signalling system that makes them an interesting model of diabetes, and now we have shown that dolphin brains show signs of Alzheimer’s identical to those seen in people.”

Without studying the behaviour of dolphins in the wild, it is difficult to know if older dolphins have similar memory problems and confusion as seen in people with Alzheimer’s disease. However, the research team do not advocate carrying out tests on captive dolphins.

The study also has implications for people on extreme calorie restriction diets hoping to dramatically extend their lifespan (as can occur in mice and fruit flies).

“If we are right, then it is already too late, by tens of thousands of years,” says Professor Lovestone. “That’s about how long ago in our evolution we are likely to have acquired the insulin resistance that gained the extended lifespan that calorie restriction would produce.”

“While a sensible diet has obvious health benefits and is important for avoiding premature death from avoidable obesity-related conditions, we think that extreme calorie restriction will not extend the human life-span.”

Professor Lovestone now hopes to use this understanding in the lab to improve the way we test new drugs for Alzheimer’s disease: “At the moment, even in mice which have been genetically engineered to have the plaques associated with Alzheimer’s disease, there are no tangles, and very little damage to brain cells.”

“This makes it difficult to find new ‘targets’ for curing the disease, as well as studying how a potential drug can change the disease.”

“But if altered insulin signalling can make an animal more susceptible to Alzheimer’s disease, we might be able produce mice that are a true model of the disease, which we can then test to find new treatments.”

The full paper, “Alzheimer’s disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging,” can be read in the journal Alzheimer’s & Dementia.


Explore further:
Could diabetes drugs curb our dementia epidemic?

More information:
Danièlle Gunn-Moore et al. Alzheimer’s disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging, Alzheimer’s & Dementia (2017). DOI: 10.1016/j.jalz.2017.08.014

Provided by:
University of Oxford

Tagged with:

About author

Related Articles